Dupilumab Safely Improves EoE Symptoms, Regardless of Prior Corticosteroid Use
Among the dupilumab treatment and placebo groups, 69% and 71% had previously used STCs, respectively.
Source: empr.com
Stay updated with breaking news from Endoscopic Reference Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among the dupilumab treatment and placebo groups, 69% and 71% had previously used STCs, respectively.
With a focus on newly approved treatments and those seemingly on the verge, this year's meeting had clear practice-changing implications, says Dr David Johnson.